<DOC>
	<DOC>NCT00216918</DOC>
	<brief_summary>The purpose of this study is to evaluate the change in neuropsychological status from baseline to 6 months post-initiation of atomoxetine treatment in children ages 6 to 10.5 diagnosed with ADHD.</brief_summary>
	<brief_title>Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>A) Patients: 1. Patients must have ADHD, be outpatients, who are at least 6 years of age and not more than 10 years 6 months of age at Visit 1 so that all testing will be completed before the child reaches age 11. 2. Patients must have moderately severe symptoms of ADHD. 3. Patients must be able to swallow study drug capsules. 1. Patients must not have Bipolar disorder, psychosis, autism, Asperger's syndrome, pervasive developmental disorder, or seizure disorder. 2. Patients must not be homeschooled. B) Controls: Subjects will be recruited by the investigator, age and gendermatched to the atomoxetinetreated patients. 1) Control subjects must be assessed to be not diagnosed with a psychiatric disorder or a medically significant disorder 1) Subjects must not be homeschooled.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>